FoxD3 deficiency promotes breast cancer progression by induction of epithelial–mesenchymal transition
Authors:
- 1 April 2014
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 446 (2) , 580-584
Abstract
No abstract availableKeywords
Funding Information
- National High Technology Research and Development Program of China (2012AA021003)
- National Natural Science Foundation of China (21177091, 81372843)
This publication has 17 references indexed in Scilit:
- FOXD3 Regulates Migration Properties and Rnd3 Expression in Melanoma CellsMolecular Cancer Research, 2011
- A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy numberLaboratory Investigation, 2010
- FOXD3 Is a Mutant B-RAF–Regulated Inhibitor of G1-S Progression in Melanoma CellsCancer Research, 2010
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Regulation of Embryonic Stem Cell Self-Renewal and Pluripotency by Foxd3Stem Cells, 2008
- The emerging roles of forkhead box (Fox) proteins in cancerNature Reviews Cancer, 2007
- In control of biology: of mice, men and FoxesBiochemical Journal, 2006
- A negative feedback loop of transcription factors that controls stem cell pluripotency and self‐renewalThe FASEB Journal, 2006
- The history of cancer epigeneticsNature Reviews Cancer, 2004
- Requirement for Foxd3 in maintaining pluripotent cells of the early mouse embryoGenes & Development, 2002